This page shows the latest Questcor Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Over the decades, other drugs superseded Acthar in many, but not all, indications, culminating in Aventis Pharmaceuticals selling the asset to Questcor for $100, 000 in 2001. ... Questcor allegedly increased the price to $750 immediately after buying the
This includes the $5.6bn deal for Questcor Pharmaceuticals last year and its purchase of Cadence Pharmaceuticals for $1.3bn.
Questcor Pharmaceuticals has won US Food and Drug Administration approval of a new indication for its for HP Acthar Gel. ... Questcor Pharmaceuticals, which specialises in drugs for difficult-to-treat diseases, has won US Food and Drug Administration (FDA
Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals). ... Quazepam. (Questcor Pharmaceuticals). Insomnia. US. Risperidone. Generic risperidone (Actavis Group).
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
All told 24% of its revenues will come from in consumer health, 62% pharmaceuticals and 14% vaccines. ... Having purchased Cadence Pharmaceuticals for $1.4bn in February of this year (Ofirmev, an iv injectable acetaminophen for pain), April saw the
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Michael Aldridge joins from Australian early development company Xenome. US biopharma Questcor Pharmaceuticals has named Michael Aldridge as its first senior VP, corporate strategic development. ... Development programmes that complement Acthar are also
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...